Plomp, J.J., Molenaar, P.C., O’Hanlon, G.M., et al. (1999) Miller Fisher Anti-GQ1b Antibodies: Alpha-Latrotoxin-Like Effects on Motor End Plates. Annals of Neurology, 45, 189-199.
https://doi.org/10.1002/1531-8249(199902)45:2<189::AID-ANA9>3.0.CO;2-T

has been cited by the following article:

• TITLE: A Patient with Post Infectious Immune Mediated Neuropathy (Miller Fisher Syndrome)

  AUTHORS: Sharlene Sanchez, Azad Esack

  KEYWORDS: Miller Fisher, Anti-Ganglioside, Demyelinating, Immune Mediated

  JOURNAL NAME: International Journal of Clinical Medicine, Vol.8 No.3, March 15, 2017

  ABSTRACT: The Miller Fisher variant is an uncommon but well known syndrome being described as a triad of areflexia, ataxia and complex ophthalmoplegia. It is characterized by antibodies against myelin that affects peripheral nerves, extraocular muscles and Schwann cells. Anti-ganglioside antibodies have been recognized in disease pathogenesis and decreasing antibody production is the mainstay of treatment. The course is usually benign with improvement after immunomodulation. This case report describes the approach to a patient suspected of having a demyelinating disorder. It delineates the subsets of immune mediated neuropathies in evaluating the diagnosis and emphasizes the need for early therapeutic intervention in achieving a good clinical outcome.